Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Andrea BacigalupoGruppo Italiano Trapianti Midollo Osseo (GITMO)

Abstract

This is an update of a randomized study on antithymocyte globulin (ATG; Thymoglobulin) before transplantation in patients undergoing unmanipulated marrow transplantation from unrelated donors. The median follow-up for surviving patients is 5.7 years. At last follow-up, chronic graft-versus-host disease (GVHD) was scored in 60% of non-ATG and in 37% of ATG patients (P=.05), and extensive chronic GVHD was present in 41% and 15%, respectively (P=.01). Chronic lung dysfunction was diagnosed in 51% versus 19% of patients (P=.005). Forced vital capacity decreased significantly with time in non-ATG patients (P=.005), but not in patients who received ATG (P=.30). The proportion of patients with Karnofsky scores of >or=90% at 4 years was 57% versus 89% in non-ATG versus ATG patients (P=.03). The actuarial 6-year survival for all patients randomized was 31% versus 44% (non-ATG versus ATG; P=.80). The cumulative incidence of transplant-related mortality was 51% versus 41% (P=.70) and of relapse was 32% versus 40% (P=.90). For patients who survived 1 year, transplant-related mortality was 25% versus 3% (P=.03), and actuarial survival was 58% versus 85% (P=.09). In conclusion, the addition of ATG to cyclosporine/methotrexate provides signif...Continue Reading

References

Feb 18, 1982·The New England Journal of Medicine·N K RamsayM E Nesbit
Nov 25, 2000·British Journal of Haematology·J FinkeR Mertelsmann
Feb 16, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeePaul J Martin
Feb 23, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Martin GoernerRainer Storb
Jan 14, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·A BacigalupoM T Van Lint

❮ Previous
Next ❯

Citations

May 29, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Gordon Guyatt, Holger Schunemann
Apr 18, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S J Fasouliotis, J G Schenker
Sep 25, 2008·Bone Marrow Transplantation·Rj Soiffer
Feb 12, 2008·Bone Marrow Transplantation·S ChunduriD Rondelli
Jul 24, 2008·Bone Marrow Transplantation·C MessinaUNKNOWN EBMT Paediatric Working Party
Jul 9, 2009·Bone Marrow Transplantation·A BacigalupoUNKNOWN Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Nov 21, 2012·Bone Marrow Transplantation·L M PrattJ Storek
Jan 18, 2013·The New England Journal of Medicine·Claudio AnasettiUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Oct 19, 2012·The New England Journal of Medicine·Claudio AnasettiUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Oct 21, 2006·Current Opinion in Hematology·Kristin Baird, Steven Z Pavletic
Sep 29, 2011·Current Opinion in Oncology·Koen van Besien
Sep 28, 2007·Current Opinion in Hematology·Ernst Holler
Jan 18, 2011·Hematology·Mohamad Mohty, Jane F Apperley
Jan 20, 2007·Blood·H Joachim Deeg
Feb 6, 2014·Respiratory Physiology & Neurobiology·Giovanni BarisioneVito Brusasco
Dec 17, 2014·Leukemia & Lymphoma·Javier Segovia, Koen van Besien
Oct 23, 2008·Expert Review of Hematology·John Koreth, Joseph H Antin
Nov 19, 2010·Expert Review of Hematology·Steven C Goldstein, David L Porter
Mar 19, 2009·Expert Opinion on Drug Metabolism & Toxicology·Karen Ballen
Feb 10, 2016·International Journal of Hematology·Kodai KuriyamaTakahiro Fukuda
Jan 19, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rosy DabasJan Storek
Apr 9, 2013·Critical Reviews in Oncology/hematology·Sebastian TheurichMichael von Bergwelt-Baildon
Apr 2, 2013·Survey of Ophthalmology·Hasanain ShikariReza Dana
Jun 7, 2011·Blood Reviews·Koen van Besien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.